British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic.

Autor:	Kennedy NA; Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.; University of Exeter, Exeter, UK., Jones GR; University of Edinburgh, Edinburgh, UK.; Western General Hospital, Edinburgh, UK., Lamb CA; Newcastle University, Newcastle upon Tyne, UK.; Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Appleby R; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Arnott I; Western General Hospital, Edinburgh, UK., Beattie RM; Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Bloom S; University College London Hospitals NHS Foundation Trust, London, UK., Brooks AJ; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Cooney R; Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; University of Birmingham, Birmingham, UK., Dart RJ; King's College London, London, UK.; The Royal Free Hospital, London, UK., Edwards C; Torbay and South Devon NHS Foundation Trust, Torquay, UK., Fraser A; University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Gaya DR; Glasgow Royal Infirmary, Glasgow, UK.; University of Glasgow, Glasgow, UK., Ghosh S; Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; University of Birmingham, Birmingham, UK., Greveson K; The Royal Free Hospital, London, UK., Hansen R; University of Glasgow, Glasgow, UK.; Royal Hospital for Children, Glasgow, UK., Hart A; St Mark's Hospital, London, UK.; Imperial College London, London, UK., Hawthorne AB; University Hospital of Wales, Cardiff, UK., Hayee B; King's College London, London, UK.; King's College Hospital NHS Foundation Trust, London, UK., Limdi JK; The Pennine Acute Hospitals NHS Trust, Manchester, UK.; University of Manchester, Manchester, UK., Murray CD; The Royal Free Hospital, London, UK., Parkes GC; Barts and the London School of Medicine and Dentistry, London, UK.; The Royal London Hospital, Barts Health NHS Trust, London, UK., Parkes M; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Patel K; St George's University Hospitals NHS Foundation Trust, London, UK., Pollok RC; St George's University Hospitals NHS Foundation Trust, London, UK.; St George's, University of London, London, UK., Powell N; Imperial College London, London, UK.; Imperial College Healthcare NHS Trust, London, UK., Probert CS; Liverpool University Hospitals NHS Foundation Trusts, Liverpool, UK.; University of Liverpool, Liverpool, UK., Raine T; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Sebastian S; Hull University Teaching Hospitals NHS Trust, Hull, UK., Selinger C; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Smith PJ; Liverpool University Hospitals NHS Foundation Trusts, Liverpool, UK., Stansfield C; Salford Royal NHS Foundation Trust, Salford, UK., Younge L; Crohn's and Colitis UK, St Albans, Hertfordshire, UK., Lindsay JO; Barts and the London School of Medicine and Dentistry, London, UK.; The Royal London Hospital, Barts Health NHS Trust, London, UK., Irving PM; King's College London, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK., Lees CW; University of Edinburgh, Edinburgh, UK charlie.lees@ed.ac.uk.; Western General Hospital, Edinburgh, UK.
Jazyk:	angličtina
Zdroj:	Gut [Gut] 2020 Jun; Vol. 69 (6), pp. 984-990. Date of Electronic Publication: 2020 Apr 17.
DOI:	10.1136/gutjnl-2020-321244
Abstrakt:	The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we have rapidly mobilised inflammatory bowel disease (IBD) centres in order that preparations can be made to protect our patients and the clinical services they rely on. This is a novel coronavirus; much is unknown as to how it will affect people with IBD. We also lack information about the impact of different immunosuppressive medications. To address this uncertainty, the British Society of Gastroenterology (BSG) COVID-19 IBD Working Group has used the best available data and expert opinion to generate a risk grid that groups patients into highest, moderate and lowest risk categories. This grid allows patients to be instructed to follow the UK government's advice for shielding, stringent and standard advice regarding social distancing, respectively. Further considerations are given to service provision, medical and surgical therapy, endoscopy, imaging and clinical trials. Competing Interests: Competing interests: For details of conflicts of interest see online supplementary table 1. (© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu